- Home
- NEGG vs BLFS Comparison
NEGG vs BLFS Comparison
Compare NEGG & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | BLFS |
|---|---|---|
| Founded | 2001 | 1987 |
| Country | United States | United States |
| Employees | 762 | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.1M | 923.5M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | NEGG | BLFS |
|---|---|---|
| Price | $22.74 | $21.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 74.3K | ★ 330.7K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ N/A | $1,060.00 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $4.70 | $17.86 |
| 52 Week High | $137.84 | $29.57 |
Technical Indicators
Market Signals| Indicator | NEGG | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 24.52 | 48.28 |
| Support Level | N/A | $19.71 |
| Resistance Level | $47.10 | $26.14 |
| Average True Range (ATR) | 2.75 | 0.96 |
| MACD | -1.20 | -0.09 |
| Stochastic Oscillator | 3.53 | 36.72 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.